News Releases
FDA Approves Rockwell's Triferic for Dialysis Patients
Rockwell Medical, Inc., announced today that the U.S. Food & Drug Administration (FDA) has approved its drug Triferic for commercial sale as an iron replacement product to maintain hemoglobin in adult patients with hemodialysis dependent chronic kidney disease.
FDA Grants Orphan Drug Status to Soliris for Kidney Transplant Patients
The FDA has granted orphan drug designation to a medication to prevent failure of a transplanted kidney immediately after transplantation.